Sunday, October 2, 2022 | Back issues
Courthouse News Service Courthouse News Service

Drug Antitrust

A federal judge refused to dismiss the Rochester Drug Cooperative’s claim that Johnson & Johnson violated more than a dozen states' consumer-protection laws by monopolizing the market for Remicade, an arthritis drug, via exclusive agreements and coercive bundled rebates.

PHILADELPHIA — A federal judge refused to dismiss the Rochester Drug Cooperative’s claim that Johnson & Johnson violated more than a dozen states' consumer-protection laws by monopolizing the market for Remicade, an arthritis drug, via exclusive agreements and coercive bundled rebates.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...